Recently, we described that PCa cells overexpressing SPARC have a lower expression of prostate epithelial markers such as E-cadherin and cytokeratin 18 and an increased expression of the mesenchymal marker vimentin. The gene discussed is SPARC; the disease is posterior cortical atrophy.